Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patient
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference15 articles.
1. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: a retrospective cohort study;Abongomera;PLoS Negl Trop Dis,2018
2. The risk and predictors of visceral leishmaniasis relapse in human immunodeficiency virus-coinfected patients in Ethiopia: a retrospective cohort study;Abongomera;Clin Infect Dis,2017
3. A comparison of the effectiveness of sodium stibogluconate monotherapy to sodium stibogluconate and paromomycin combination for the treatment of severe post kala azar dermal leishmaniasis in South Sudan —A retrospective cohort study;Abongomera;PLoS One,2016
4. Leishmania and human immunodeficiency virus coinfection: the first 10 years;Alvar;Clin Microbiol Rev,1997
5. Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy;Belay;Ann Trop Med Parasitol.,2006
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The leishmaniases in Kenya: A scoping review;PLOS Neglected Tropical Diseases;2023-06-01
2. Feasibility of Therapeutic Vaccine for the Management and Control of VL;Challenges and Solutions Against Visceral Leishmaniasis;2023
3. Visceral leishmaniasis (kala-azar) caused by L. mexicana in a patient with AIDS;Baylor University Medical Center Proceedings;2022-10-20
4. Immune recovery-related patterns of post kala-azar dermal and ocular leishmaniasis in people living with HIV;AIDS;2022-07-16
5. In-vitro evaluation of nano-liposomal formulation of Fluconazole and Amphotericin B against visceral leishmaniasis;Research Journal of Pharmacy and Technology;2021-09-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3